Supplementary Components01: Shape S1. (50 ng/well) plus clear vector (Wt:vector percentage 1:7), the Wt hTSHR cDNA (50 ng/well) plus the hFSHR R556A mutant cDNA (Wt:mutant ratios 1:6 and 1:7) or the Wt hTSHR cDNA (50 ng/well) plus the R618A hFSHR mutant cDNA (ratios 1:4 and 1:7). GnRH agonist (Buserelin)-stimulated inositol phosphate (IP) production in HEK-293 co-transfected with constant amounts (25 ng/well) of the chimeric hGnRHR-cfCtail cDNA and the hFSHR R556A or R618A mutant cDNAs at the chimera:mutant cDNA ratios indicated. BMS512148 inhibitor database Wild-type, chimeric and mutant receptors cDNAs were in pcDNA3.1. NIHMS185438-supplement-02.pdf (20K) GUID:?DC526683-34BE-437C-B402-3F52A09D564C 03: Figure S3. Total cAMP accumulation in HEK-293 cells co-transfected with constant amounts of the Wt 2-adrenergic receptor (2AR) (A and B) or the dopamine D1 receptor (D1R) (C and D) cDNA (50 ng/well) plus empty vector (Wt:vector 1:7) or plus the hFSHR R556A (A and C) or R618A (B and D) mutant cDNAs at the indicated Wt:mutant receptor cDNA ratios, and stimulated with increasing doses of agonist (isoproterenol or bromocriptine). Agonist-stimulated cAMP accumulation was not altered when the Wt receptors were coexpressed with the hFSHR mutants. Wild-type and mutant receptors cDNAs were in pcDNA3.1. BCL2L5 NIHMS185438-supplement-03.pdf (28K) GUID:?6F39351E-53D8-4FD3-979E-2AB1963980F1 04: Figure S4. Specific [125I]-FSH binding to HEK-293 cells co-transfected with the Wt hFSHR H534-V582 (A) or A590-N678 (B) fragment cDNAs, the Wt hFSHR cDNA and the mutant R556A hFSHR cDNA. The insets display the matching schematics from the transmembrane domains 5 to 7, the IL3 as well as the Ctail from the hFSHR, with the spot from the receptor encoded with the cDNA fragment co-transfected in dark circles. Mutant and Wild-type receptors cDNAs had been in pSG5, whereas the hFSHR fragments cDNAs had been in pcDNA3.1. *p 0.05 Wt FSHR co-transfected using the R556A mutant as well as the clear vector. The full total results shown stand for the mean SEM from 3 independent experiments. NIHMS185438-health supplement-04.pdf (47K) GUID:?6C700C09-3B5F-4D13-B6BE-EA8374D51DBB 05: Body S5. Aftereffect of BMS512148 inhibitor database co-transfecting the Wt hFSHR F612-N678 fragment cDNA in the dominant unwanted effects from the R618A hFSHR mutant. A: The graph displays maximal FSH-stimulated total cAMP deposition in HEK-293 cells co-transfected using the Wt hFSHR cDNA plus clear vector, the Wt hFSHR cDNA in addition to the R618A hFSHR mutant cDNA (proportion 1:7), or the Wt hFSHR cDNA in addition to the hFSHR R618A cDNA, plus raising levels of the Wt hFSHR F612-N678 fragment cDNA. Schematic from the transmembrane domains 5 to 7, the IL3, as well as the Ctail from the hFSHR displaying in dark circles the spot from the receptor encoded with the cDNA fragment transfected. B: Particular [125I]-FSH binding to HEK-293 cells co-transfected using the cDNAs indicated in the bottom from the graph. Wild-type and mutant receptors cDNAs had been in pSG5, whereas the hFSHR fragments cDNAs had been in pcDNA3.1. The outcomes proven represent the mean SEM from 3 indie tests. *p 0.05 all other conditions; ?p 0.01 Wt hFSHR + hFSHR R618A + vacant vector. NIHMS185438-supplement-05.pdf (33K) GUID:?6723DA29-6FDF-4689-AF46-30FDCA6D68AD 06: Physique S6. Co-immunoprecipitation of Wt hFSHR with expression-deficient mutants. To address whether mutant hFSHRs can dimerize/oligomerize with Wt hFSHR, HEK-293T cells were co-transfected with (A) Wt myc epitope-tagged hFSHR or (B) pShuttle to balance DNA. Also, either hFSHR R556A-FLAG, hFSHR R618A4-FLAG or pShuttle was cotransfected BMS512148 inhibitor database in either case. Cell lysates were generated 24 hours later and immunoprecipitations (IPs) were performed with anti-myc mAb or isotype control mAb IgG1. Detection was with anti-FLAG M2 HRP conjugate (1:1000). After substrate development, the blots were subjected to a 30 min exposure. Expression of the mutants was quite low in these experiments; visualization of the FLAG-tagged epitope was likely only possible because of the exquisite sensitivity of the M4 anti-FLAG antibody. Immunoblot analysis of immunoprecipitated samples with anti-FLAG mAb HRP conjugate revealed only high molecular weight species (175 kDa) which is likely a nondissociable immature form of FLAG-tagged hFSHR (62 kDa) associated with a myc-tagged hFSHR and probably a molecular chaperone as well (Thomas et al., 2007). Although no myc-tagged hFSHR was detected when the blots were reprobed with anti-myc mAb, this band specifically co-immunoprecipitated with myc-tagged Wt hFSHR. Immunoblot analysis of the whole BMS512148 inhibitor database cell lysates (pre-IP) with anti-FSHR extracellular domain name mAb 106.105, showed that Wt hFSHR-myc protein levels were quite low, but higher than FSHR R556ACFLAG. The hFSHR R618ACFLAG mutant was virtually undetectable. NIHMS185438-supplement-06.pdf (62K) GUID:?CBE2324F-DC71-482A-840E-869544F7A35F 07. NIHMS185438-supplement-07.pdf (9.9K) GUID:?DFAD3C69-00FF-4427-A9C0-34EAAD1F14B6 Abstract Current evidence indicates that G protein-coupled receptors form dimers that may affect biogenesis and membrane targeting of the complexed receptors. We here analyzed whether expression-deficient follicle-stimulating hormone receptor (FSHR) mutants exert dominant negative actions on wild-type.